How the MIND diet may protect against dementia

FHS
August 20, 2024
10:26 am

Researchers utilize transcriptomic data to examine the protective effects of the MIND diet in reducing the risk of dementia and slowing cognitive decline.

Gilead’s lenacapavir applications gain EMA validation

Gilead’s lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other antiretrovirals. Credit: Sundry Photography/Shutterstock. Gilead

February 25, 2025

New WHO classification of kidney tumors integrates molecular diagnostics

Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types.

June 18, 2024

UroGen acquires IconOVir’s oncolytic virus assets

UroGen has issued $4m in ordinary shares to IconOVir. Credit: MacroEcon/Shutterstock. UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to

February 21, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.